tiprankstipranks
Trending News
More News >
Predictive Oncology Inc (POAI)
NASDAQ:POAI

Predictive Oncology (POAI) Price & Analysis

Compare
468 Followers

POAI Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
TechnologyThe proprietary AI platform PEDAL has demonstrated the potential to identify biomarkers in cancer patients, making it an attractive licensing target.
Bears Say
Financial PerformancePredictive Oncology reported lower than expected revenue for 3Q24, indicating potential financial challenges.
Strategic UncertaintyThe company is undergoing a strategic review, which includes evaluating alternatives like a sale of the company or its assets, creating uncertainty.

Financials

Options Prices

Currently, No data available
---

Ownership Overview

1.57%1.33%0.12%97.77%
0.12% Other Institutional Investors
97.77% Public Companies and Individual Investors

POAI FAQ

What was Predictive Oncology Inc’s price range in the past 12 months?
Predictive Oncology Inc lowest stock price was $0.55 and its highest was $3.06 in the past 12 months.
    What is Predictive Oncology Inc’s market cap?
    Predictive Oncology Inc’s market cap is $7.59M.
      When is Predictive Oncology Inc’s upcoming earnings report date?
      Predictive Oncology Inc’s upcoming earnings report date is Aug 07, 2025 which is in 29 days.
        How were Predictive Oncology Inc’s earnings last quarter?
        Predictive Oncology Inc released its earnings results on May 15, 2025. The company reported -$0.34 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.34.
          Is Predictive Oncology Inc overvalued?
          According to Wall Street analysts Predictive Oncology Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Predictive Oncology Inc pay dividends?
            Predictive Oncology Inc does not currently pay dividends.
            What is Predictive Oncology Inc’s EPS estimate?
            Predictive Oncology Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Predictive Oncology Inc have?
            Predictive Oncology Inc has 8,931,621 shares outstanding.
              What happened to Predictive Oncology Inc’s price movement after its last earnings report?
              Predictive Oncology Inc reported an EPS of -$0.34 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.804%.
                Which hedge fund is a major shareholder of Predictive Oncology Inc?
                Currently, no hedge funds are holding shares in POAI

                Company Description

                Predictive Oncology Inc

                Predictive Oncology (POAI) is a biotechnology company focused on the development of innovative solutions in the field of cancer research and treatment. The company leverages artificial intelligence (AI) and machine learning to enhance the precision and effectiveness of oncology therapies. POAI operates across multiple sectors, including drug discovery, personalized medicine, and biopharmaceutical research, providing advanced tools and technologies to improve patient outcomes.
                Similar Stocks
                Company
                Price & Change
                Follow
                Harvard Bioscience
                Harvard Bioscience
                Retractable Technologies
                Retractable Technologies
                EKSO BIONICS
                EKSO BIONICS
                NexGel Inc
                NexGel Inc
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis